Cardiovascular disease (CVD) is often thought to be a problem of wealthy, industrialized nations. The term “cardiovascular disease” is used throughout the report to refer to cardiac disease, vascular diseases of the brain and kidney, and peripheral vascular disease. The report’s main focus is ...on the major contributors to global CVD mortality, coronary heart disease and stroke, and on the major modifiable risk factors for cardiovascular diseases. In fact, as the leading cause of death worldwide, CVD now has a major impact not only on developed nations but also on low and middle income countries, where it accounts for nearly 30 percent of all deaths. The terms “developed” and “high income countries” are used interchangeably throughout the report to refer to countries classified by the World Bank as high income economies. The terms “developing” and “low and middle income countries” are used interchangeably throughout the report to refer to countries classified by the World Bank as low, lower middle, and upper middle income economies. The increased prevalence of risk factors for CVD and related chronic diseases in developing countries, including tobacco use, unhealthy dietary changes, reduced physical activity, increasing blood lipids, and hypertension, reflects significant global changes in behavior and lifestyle. The term “chronic diseases” is used throughout the report to refer to CVD and the following related chronic diseases that share many common risk factors: diabetes, cancer, and chronic respiratory disease. These changes now threaten once-low-risk regions, a shift that is accelerated by industrialization, urbanization, and globalization. The potentially devastating effects of these trends are magnified by a deleterious economic impact on nations and households, where poverty can be both a contributing cause and a consequence of chronic diseases. The accelerating rates of unrecognized and inadequately addressed CVD and related chronic diseases in both men and women in low and middle income countries are cause for immediate action.
more
The ERF provides WHO staff with essential guidance on how the Organization manages the assessment, grading and response to public health events and emergencies with health consequences, in support of Member States and affected communities. The ERF adopts an all-hazards approach and it is therefore a...pplicable in all acute public health events and emergencies.
This version (2024) of the WHO ERF has been developed following extensive consultation across the three levels of the Organization and response experiences over the last five years of emergency response. Key areas have been updated to improve the accountability, predictability, timeliness and effectiveness of WHO’s response to emergencies.
more
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...ation and a recommendation on hydroxychloroquine. It follows the publication of six trials synthesized in a living network meta-analysis (NMA).
more
Für behinderte Menschen und ihre Familien ist es nicht immer leicht, sich im Dickicht der Sozialleistungen zu Recht zu finden. Kommen sprachliche Probleme hinzu, entstehen weitere Barrieren. Die Broschüre „Mein Kind ist behindert – diese Hilfen gibt es“ vermittelt einen ersten Überblick üb...er die Leistungen, die Menschen mit Behinderungen zustehen.
Sie ist erhältlich in Deutsch, in Türkisch-Deutsch, in Deutsch-Russisch, in Arabisch und in Vietnamesisch.
more
La política de salvaguarda infantil de la CBM se basa en la Convención sobre los Derechos del Niño de la ONU de 1989 (y en sus protocolos facultativos) y en la legislación nacional de protección infantil de Alemania, así como en la de los países participantes en el programa de la CBM y la nor...mativa de Keeping Children Safe. Esta política ha sido creada porque la seguridad y el respeto a la dignidad de todos los niños y las niñas es un principio básico del trabajo de la CBM. A efectos de esta política, se considera niño o niña a cualquier persona de menos de 18 años de edad.
more
Rapport sur les populations clès
Accessed November 2017
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...tion pumps, X-ray, ultrasound and CT scanners as well as personal protective equipment. In order to facilitate access to quality assured priority medical devices, the document also includes technical and performance characteristics, related standards, accessories and consumables. It is intended for policy-makers and planning officers in Ministries of Health, procurement and regulatory agencies, intergovernmental and international agencies as well as the medical device industry.
This document is an update to the List of priority medical devices for COVID-19 case management and Technical specifications for invasive and non-invasive ventilators for COVID-19.
This document complements the Technical specifications of personal protective equipment for COVID-19.
more
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Une activité de résilience aux traumatismes pour le projet de CRS-WARO Action pour la protection et l'intégration des migrants en Afrique (APIMA).
Ce manuel montre comment organiser un atelier qui aide les participants à trouver une identité et une vision de leur vie qui équilibrent les expé...riences positives et négatives afin de leur donner un sens de direction personnelle et un espoir pour l’avenir.
more
ERS is made up of over 35,000 respiratory clinicians, scientists and allied healthcare professionals, spanning more than 160 countries worldwide. Members are central to the Society and actively participate in setting the agenda across all ERS activities. Members have access to and enjoy a comprehens...ive range of benefits.
more
In India, in response to the above and guided by our counterparts in the government of India, the UN agencies have developed the Novel Coronavirus Disease Joint Health Response Plan by UN Agencies and Partners, led by WHO-India, in close collaboration with the Ministry of Health and Family Welfare, ...and with the support of other development partners. The UN in India is also preparing a COVID-19 Socio-economic Response and Recovery Plan, in partnership with the government.
more
WEB Foundationis a disability focused non- Governmental Organization in Ghana committed to promoting the rights and social inclusion of persons with disabilities in Ghana
L’utilisation des services de santé de base est l’un des facteurs clefs favorisant une meilleure santé des populations. Conceptuellement, si la qualité des services est l’une des explications du niveau d’utilisation, cette étude a essayé de montrer aussi l’importance d’un ensemble d...’autres facteurs qui devraient être pris en compte pour améliorer la fréquentation des services de santé. Les résultats de cette étude indiquent que pour le dernier épisode de maladie, plus de 92% des malades ont recouru à différentes structures des soins modernes et 7,4% ont fait recours à la médecine traditionnelle. Pour la santé maternelle, l’utilisation des méthodes contraceptives est de 29.5% et 73% d’accouchements ont été assistés par un personnel qualifié. Parmi les 96% des femmes qui ont consulté les services de CPN pendant la grossesse, seulement 24% ont complété les quatre visites standards de CPN.
more
El objetivo del presente documento consiste en ofrecer
orientaciones provisionales sobre la definición de los casos
de SGB y las estrategias para tratar el síndrome en el
contexto del brote de virus de Zika y de su posible relación
con el SGB. Asimismo, pretende servir como base para la
elab...oración de protocolos clínicos y políticas sanitarias
locales relacionadas con la atención a los pacientes con
SGB. En marzo de 2016 se organizará una reunión de
expertos para elaborar más orientaciones sobre la
identificación y el tratamiento del SGB y otros posibles
trastornos neurológicos en el contexto de la transmisión del
virus de Zika.
more
Informe elaborado en el 2004 por la Organización Mundial de la Salud (OMS) Departamento de Salud Mental y Abuso de Sustancias en colaboración con la Fundación Victorian para la Promoción de la Salud y la Universidad de Melbourne. Este informe tiene el objetivo de activar la dimensión de la salu...d mental en la promoción de la salud; describe los conceptos relacionados con la promoción de la salud mental, la evidencia emergente para la efectividad de las intervenciones y las implicaciones de las políticas y prácticas de la salud pública.
more
1 March 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
NUDOR’s first strategic plan (2010-2016) focused on establishing NUDOR as a viable, well-run organisation. Significant progress has been made towards these aims and therefore the strategy and has been reviewed by NUDOR board, secretariat and member organisations. The updated strategic plan now cov...ers the period 2015 – 2020 for which three strategic aims have been agreed.
1. Representation and accountability: NUDOR will be accountable to and effectively represent members’ interests through the delivery of projects and priorities agreed by member organisations, and by facilitating joint working amongst members.
2. Capacity building and resource mobilization: NUDOR and its member organisations are strengthened to fulfil its mandates by developing its technical skills, research and insight, sustainability and outreach.
3. Advocacy and influencing: NUDOR will work to ensure that the needs and rights of all persons with disabilities are recognised by all, mainstreamed in laws and policies at all levels of government, and in programmes of other institutions focusing on areas of education, health and poverty reduction.
more
HIV testing programmes need to ensure that all clients who test for HIV are provided with correct diagnoses. The accuracy of HIV testing is critical to prevent misdiagnosis, as the consequences of giving an incorrect test result can be serious for clients, HIV testing services, HIV programmes and pu...blic health.
With the evolution of global HIV epidemiology, HIV testing approaches must also evolve to maintain accuracy and efficiency in population-level diagnosis. Reports suggest that misdiagnosis of HIV status may occur when suboptimal testing algorithms and out-of-date testing strategies are used. As a result of changing epidemiology and declining HIV positivity in testing, WHO recommends all countries use a standard three-test strategy to ensure a PPV of at least 99%, minimizing false-positive misdiagnosis. The WHO-recommended HIV testing strategy, along with quality assurance measures such as retesting to verify a positive diagnosis prior to initiation of HIV treatment, is cost-effective as it prevents misdiagnosis and unnecessary initiation of costly lifelong treatment.
This implementation guide provides practical advice on switching to a three-test strategy and instituting other measures that can help national HIV programmes deliver high-quality, accurate HIV testing services and ensure that misdiagnosis is minimized.
more